Corpus ID: 4117403

Vitamin C and Cancer-Storm of Controversy

@inproceedings{Levine2010VitaminCA,
  title={Vitamin C and Cancer-Storm of Controversy},
  author={S. Levine and Nicholas Calvino},
  year={2010}
}
Nicholas Calvino DC is a practising clinician, nutritional consultant and author and lecturer on the subject of health and nutrition. He is currently the president of Natural Health Partners, LLC, a practice 'enhancement' company focusing on assisting doctors in marketing and managing secondary profit centres. He can be contacted at PO Box 160, North Street, MI 48049; Tel: 810-3856737; drcalvino@msn.com 
1 Citations

Tables from this paper

To Restrict the Growth of Cancer and Convert it into a Cancer without Disease or Remission by Changing Dietary Patterns
TLDR
A gene that codes for Kirsten rat sarcoma viral oncogene homolog in Humans and a gene found in Rous Sarcoma virus that encodes a tyrosine kinase are identified. Expand

References

SHOWING 1-10 OF 24 REFERENCES
Possible interactions between dietary antioxidants and chemotherapy.
TLDR
Potential interactions and areas of concern are described and several potential courses of action that clinicians may take when patients indicate that they are taking or plan to use alternative therapies are suggested. Expand
Vitamin and mineral supplement use is associated with reduced risk of prostate cancer.
TLDR
It is suggested that multivitamin use is not associated with prostate cancer risk, but use of individual supplements of zinc, vitamin C, and vitamin E may be protective. Expand
Antioxidants and cancer therapy II: quick reference guide.
The previous lengthy review concerning the effects of antioxidant compounds used concurrently with radiotherapy and chemotherapy has been reduced to a reference guide. There are only three presentlyExpand
Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.
TLDR
The two groups showed no appreciable difference in changes in symptoms, performance status, appetite or weight, and were unable to show a therapeutic benefit of high-dose vitamin C treatment. Expand
Epidemiologic evidence regarding vitamin C and cancer.
  • G. Block
  • Medicine
  • The American journal of clinical nutrition
  • 1991
TLDR
The epidemiologic and biochemical evidence indicate an important role for vitamin C in cancer prevention, and several different factors in fruits and vegetables probably act jointly. Expand
Vitamin C exhibits pro-oxidant properties
TLDR
It is reported here that vitamin C administered as a dietary supplement to healthy humans exhibits a pro-oxidant, as well as an antioxidant, effect in vivo. Expand
New evidence for antioxidant properties of vitamin C.
TLDR
It is concluded that ascorbic acid is an antioxidant and that doses up to 5,000 mg neither induce mutagenic lesions nor have negative effects on NK cell activity, apoptosis, or cell cycle. Expand
Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort.
  • E. Jacobs, C. Connell, +6 authors M. Thun
  • Medicine
  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2001
TLDR
After adjustment for multiple colorectal cancer risk factors, regular use of vitamin C or E supplements, even long-term use, was not associated with coloreCTal cancer mortality. Expand
High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy.
TLDR
This work proposes a working hypothesis that multiple antioxidant vitamin supplements together with diet and lifestyle modifications may improve the efficacy of standard and experimental cancer therapies. Expand
A Review of Recent Results Addressing the Potential Interactions of Antioxidants with Cancer Drug Therapy
TLDR
The available data suggest a rational basis for the continued use of selected antioxidant agents as therapeutic adjuncts in cancer therapy, with such use also offering a potential to abrogate the carcinogenic process and mutation-driven drug resistance, but convincing data and widespread acceptance of such a role is dependent on additional, appropriately relevant trials. Expand
...
1
2
3
...